These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8951981)

  • 1. Ritanserin blocks DOI-altered embryonic motility and posthatch learning in the developing chicken.
    Bollweg G; Sparber S
    Pharmacol Biochem Behav; 1996 Nov; 55(3):397-403. PubMed ID: 8951981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between midembryonic 5-HT2 agonist and/or antagonist exposure and detour learning by chickens.
    Bollweg G; Sparber SB
    Pharmacol Biochem Behav; 1998 May; 60(1):47-53. PubMed ID: 9610923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive stimulation of serotonin2 (5-HT2) receptors during late development of chicken embryos causes decreased embryonic motility, interferes with hatching, and induces herniated umbilici.
    Sparber SB; Rizzo A; Berra B
    Pharmacol Biochem Behav; 1996 Mar; 53(3):603-11. PubMed ID: 8866961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic cocaine exposure and corticosterone: serotonin(2) receptor mediation.
    Larson EB; Schrott LM; Bordone L; Sparber SB
    Pharmacol Biochem Behav; 2001; 69(1-2):71-5. PubMed ID: 11420070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and neuroendocrine assessment of ritanserin exposure in the developing chicken: lack of toxicity at effective doses.
    Bollweg G; Wei YX; Sparber SB
    Pharmacol Biochem Behav; 1998 May; 60(1):175-81. PubMed ID: 9610940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a serotonin-mediated effect of cocaine causing vasoconstriction and herniated umbilici in chicken embryos.
    Zhang X; Schrott LM; Sparber SB
    Pharmacol Biochem Behav; 1998 Mar; 59(3):585-93. PubMed ID: 9512060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
    Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
    J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
    González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA
    Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic "binge" cocaine exposure alters neural-immune and neural-endocrine interactions in young chickens: involvement of serotonin(2) receptors.
    Schrott LM; Sparber SB
    Brain Res Dev Brain Res; 2001 Sep; 130(1):99-107. PubMed ID: 11557098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
    Rittenhouse PA; Bakkum EA; Van de Kar LD
    J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist.
    Rinaldi-Carmona M; Bouaboula M; Congy C; Oury-Donat F; Simiand J; Shire D; Casellas P; Soubrié P; Brelière JC; Le Fur G
    Eur J Pharmacol; 1993 Jun; 246(1):73-80. PubMed ID: 8354344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-field and LPS-induced sickness behavior in young chickens: effects of embryonic cocaine and/or ritanserin.
    Schrott LM; Getty ME; Wacnik PW; Sparber SB
    Pharmacol Biochem Behav; 1998 Sep; 61(1):9-17. PubMed ID: 9715802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP; Pinheiro G; Alves SH; Ferreira G; Mendes M; Faria L; Macedo CE; Motta V; Landeira-Fernandez J
    Psychopharmacology (Berl); 2005 Nov; 182(3):345-54. PubMed ID: 16133141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOI-induced inhibition of copulatory behavior in male rats: reversal by 5-HT2 antagonists.
    Watson NV; Gorzalka BB
    Pharmacol Biochem Behav; 1991 Jul; 39(3):605-12. PubMed ID: 1784589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the inhibitory adrenergic alpha 2 and serotonergic 5-HT1A components of cocaine's actions on the DOI-induced head-twitch response in 5-HT2-receptor supersensitive mice.
    Darmani NA
    Pharmacol Biochem Behav; 1993 Jun; 45(2):269-74. PubMed ID: 8392199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
    Rabin BC; Guo TZ; Gregg K; Maze M
    Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks.
    Schrott LM; Sweeney WA; Bodensteiner KE; Sparber SB
    Pharmacol Biochem Behav; 1999 Sep; 64(1):81-8. PubMed ID: 10495001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.